| 1 |
GBD 2013 Mortality and Causes of Death Collaborators. Global，regional，and national age-sex specific all-cause and cause-specific mortality for 240 causes of death，1990-2013： a systematic analysis for the Global Burden of Disease Study 2013［J］. Lancet，2015，385（9963）：117-171.
|
| 2 |
龙政，刘威，齐金蕾，等. 1990-2019年中国慢性呼吸系统疾病死亡情况及变化趋势［J］. 中华流行病学杂志，2022，43：14-21.
|
| 3 |
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention and management of COPD： 2024 Report［EB/OL］. 2024.
|
| 4 |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组，中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南（2021年修订版）［J］. 中华结核和呼吸杂志，2021，44（3）：170-205.
|
| 5 |
Nici L，Mammen MJ，Charbek E，et al. Pharmacologic management of chronic obstructive pulmonary disease. an official american thoracic society clinical practice guideline［J］. Am J Respir Crit Care Med，2020，201（9）：e56-e69.
|
| 6 |
Sciurba FC，Ernst A，Herth FJ，et al. A randomized study of endobronchial valves for advanced emphysema［J］. N Engl J Med，2010，363（13）：1233-1244.
|
| 7 |
Li S，Wang G，Wang C，et al. The REACH trial： a randomized controlled trial assessing the safety and effectiveness of the spiration？Valve system in the treatment of severe emphysema ［ J］.Respiration，2019，97（5）：416-427.
|
| 8 |
Deslée G，Mal H，Dutau H，et al. Lung volume reduction coil treatment vs usual care in patients with severe emphysema： the REVOLENS randomized clinical trial［J］. JAMA，2016，315（2）：175-184.
|
| 9 |
Herth FJ，Valipour A，Shah PL，et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema：6-month results of the multicentre，parallel-group，open-label，randomised controlled STEP-UP trial［J］. Lancet Respir Med，2016，4（3）：185-193.
|
| 10 |
ComeCE，Kramer MR，Dransfield MT，et al. A randomised trial of lung sealant versus medical therapy for advanced emphysema［J］.Eur Respir J，2015，46（3）：651-162.
|
| 11 |
Shah PL，Herth FJ，van Geffen WH，et al. Lung volume reduction for emphysema［J］. Lancet Respir Med，2017，5（2）：147-156.
|
| 12 |
Hellmann F，Verdi M，Schlemper BR Jr，et al. 50th anniversary of the Declaration of Helsinki： the double standard was introduced［J］. Arch Med Res，2014，45（7）：600-601.
|
| 13 |
HARVARD UNIVERSITY. Chest Imaging Platform （CIP） ［EB/OL］. ［2024/02/24 Accessed］.
|
| 14 |
Jaeschke R，Singer J，Guyatt GH. Measurement of health status.Ascertaining the minimal clinically important difference［J］. Control Clin Trials，1989，10（4）：407-415.
|
| 15 |
Sedaghat AR. Understanding the minimal clinically important difference （MCID） of patient-reported outcome measures ［J］.Otolaryngol Head Neck Surg，2019，161（4）：551-560.
|
| 16 |
Pellegrino R，Viegi G，Brusasco V，et al. Interpretative strategies for lung function tests［J］. Eur Respir J，2005，26（5）：948-968.
|
| 17 |
Park TS，Hong Y，Lee JS，et al. Bronchoscopic lung volume reduction by endobronchial valve in advanced emphysema： the first Asian report［J］. Int J Chron Obstruct Pulmon Dis，2015，10：1501-1511.
|
| 18 |
Posthuma R，Vaes AW，Walraven KHM，et al. Implementation of bronchoscopic lung volume reduction using one-way endobronchial valves： a retrospective single-centre cohort study［J］. Respiration，2022，101（5）：476-484.
|
| 19 |
Dumanli A，Metin B，Gunay E. Endobronchial valve vs coil for lung volume reduction in emphysema： results from a tertiary care centre in Turkey［J］. Ann Saudi Med，2020，40（6）：469-476.
|
| 20 |
Sidhu C，Wilsmore N，Shargill N，et al. Lung volume reduction for emphysema using one-way endobronchial valves： an Australian cohort［J］. Medicine （Baltimore），2023，102（31）：e34434.
|
| 21 |
Yu H，Yang Z，Zhu M，et al. Endobronchial valve therapy for patients with advanced emphysema. A report from a tertiary care center in China［J］. Saudi Med J，2022，43（12）：1397-1401.
|
| 22 |
Hopkinson NS，Kemp SV，Toma TP，et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD［J］. Eur Respir J，2011，37（6）：1346-1351.
|
| 23 |
Valipour A，Herth FJ，Burghuber OC，et al. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy［J］. Eur Respir J，2014，43（2）：387-396.
|
| 24 |
van Dijk M，Klooster K，Hartman JE，et al. Change in dynamic hyperinflation after bronchoscopic lung volume reduction in patients with emphysema［J］. Lung，2020，198（5）：795-801.
|
| 25 |
Fumat R，Dupuis M，Mallah S，et al. Impact of bronchoscopic lung volume reduction with endobronchial valves on dynamic hyperinflation： results from the PIERCE study［J］. Respirology，2023，28（6）：525-532.
|
| 26 |
Pizarro C，Schueler R，Hammerstingl C，et al. Impact of endoscopic lung volume reduction on right ventricular myocardial function［J］. PLoS One，2015，10（4）：e0121377.
|
| 27 |
Fiorelli A，Cascone R，Natale G，et al. Cardio-pulmonary changes after bronchoscopic lung volume reduction with endobronchial oneway valves［J］. Lung，2020，198（3）：565-573.
|
| 28 |
van der Molen MC，Hartman JE，Vanfleteren LEGW，et al.Reduction of lung hyperinflation improves cardiac preload，contractility，and output in emphysema： a clinical trial in patients who received endobronchial valves［J］. Am J Respir Crit Care Med，2022，206（6）：704-711.
|
| 29 |
Wallbridge P，Hew M，Parry SM，et al. Reduction of COPD hyperinflation by endobronchial valves improves intercostal muscle morphology on ultrasound［J］. Int J Chron Obstruct Pulmon Dis，2020，15：3251-3259.
|
| 30 |
Brindel A，Fumat R，Dupuis M，et al. Bronchoscopic lung volume reduction with endobronchial valves improves respiratory muscle function in patients with severe emphysema［J］. Respir Med Res，2023，84：101030.
|
| 31 |
Davey C，Zoumot Z，Jordan S，et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures （ the BeLieVeR-HIFi study）： a randomised controlled trial［J］. Lancet，2015，386（9998）：1066-1073.
|
| 32 |
Welling JBA，Hartman JE，van Rikxoort EM，et al. Minimal important difference of target lobar volume reduction after endobronchial valve treatment for emphysema［J］. Respirology，2018，23（3）：306-310.
|
| 33 |
Hopkinson NS，Toma TP，Hansell DM，et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema［J］. Am J Respir Crit Care Med，2005，171（5）：453-460.
|